v3.25.2
Summary of Significant Accounting Policies (Details Narrative)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jul. 02, 2025
Segment
Nov. 30, 2024
USD ($)
Sep. 30, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
Segment
$ / shares
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Property, Plant and Equipment [Line Items]                    
Number of operating segments | Segment 1                  
Sonnet BioTherapeutics Holdings, Inc. [Member]                    
Property, Plant and Equipment [Line Items]                    
Number of operating segments | Segment                 1  
Impairment charges of long-lived assets                 $ 0 $ 0
Deferred offering costs     $ 15,000           15,000 49,988
Cash refund             The cash refund is available to eligible companies with annual aggregate revenues of less than $20.0 million (Australian) during the reimbursable period.      
Tax incentive     $ 762,078   $ 597,393   $ 597,393   762,078 786,574
Other income         $ 720,102 $ 4,327,946 $ 4,327,946
Reverse stock split description     1-for-8 reverse stock split              
Warrants to purchase common stock | shares           187,500   187,500    
Warrant, shares | shares     1,265,972   5,789,600   5,789,600   1,265,972  
Cash refund (payment) related to tax incentive program         $ 300,000 $ 100,000 $ 600,000 $ 500,000    
Proceeds from income tax refunds                   $ 800,000
Sonnet BioTherapeutics Holdings, Inc. [Member] | Prefunded October 2023 Warrants [Member]                    
Property, Plant and Equipment [Line Items]                    
Warrants to purchase common stock | shares     99,687   99,687 99,687 99,687 99,687 99,687  
Exercise price | $ / shares     $ 0.0008   $ 0.0008 $ 0.0008 $ 0.0008 $ 0.0008 $ 0.0008  
Warrant, shares | shares     187,500           187,500  
Sonnet BioTherapeutics Holdings, Inc. [Member] | Series B Warrants [Member]                    
Property, Plant and Equipment [Line Items]                    
Warrants to purchase common stock | shares                   17
Exercise price | $ / shares                   $ 0.25
Sonnet BioTherapeutics Holdings, Inc. [Member] | Prefunded December Two Thousand Twenty Four Warrants [Member]                    
Property, Plant and Equipment [Line Items]                    
Exercise price | $ / shares         $ 0.0001   $ 0.0001      
Warrant, shares | shares         545,500   545,500      
Sonnet BioTherapeutics Holdings, Inc. [Member] | Minimum [Member]                    
Property, Plant and Equipment [Line Items]                    
Research and development credits tax benefits             80.00%   80.00%  
Sonnet BioTherapeutics Holdings, Inc. [Member] | Research and Development Tax Incentive Program [Member]                    
Property, Plant and Equipment [Line Items]                    
Cash refund                 The cash refund is available to eligible companies with annual aggregate revenues of less than $20.0 million (Australian) during the reimbursable period.  
Tax incentive         $ 600,000   $ 600,000     $ 800,000
Cash refund   $ 700,000   $ 800,000            
Change in foreign exchange rates       $ 100,000            
Cash refund expected to be received                   $ 800,000
Proceeds from income tax refunds                 $ 700,000